科室与专家门诊

妙佑医疗国际是美国规模最大、经验最丰富的医疗机构之一,在亚利桑那州、佛罗里达州和明尼苏达州都设有院区。我们的工作人员涉及数十种专业,通过齐心协力确保高品质治疗与成功康复。

行此手术的医生

编辑搜索过滤条件
close

缩小搜索范围

  1. 查找姓氏以该字母开头的医生 A
  2. 查找姓氏以该字母开头的医生 B
  3. 查找姓氏以该字母开头的医生 C
  4. 未找到姓氏以该字母开头的医生 D
  5. 未找到姓氏以该字母开头的医生 E
  6. 查找姓氏以该字母开头的医生 F
  7. 查找姓氏以该字母开头的医生 G
  8. 查找姓氏以该字母开头的医生 H
  9. 查找姓氏以该字母开头的医生 I
  10. 未找到姓氏以该字母开头的医生 J
  11. 查找姓氏以该字母开头的医生 K
  12. 查找姓氏以该字母开头的医生 L
  13. 未找到姓氏以该字母开头的医生 M
  14. 未找到姓氏以该字母开头的医生 N
  15. 未找到姓氏以该字母开头的医生 O
  16. 查找姓氏以该字母开头的医生 P
  17. 未找到姓氏以该字母开头的医生 Q
  18. 未找到姓氏以该字母开头的医生 R
  19. 查找姓氏以该字母开头的医生 S
  20. 主动 查找姓氏以该字母开头的医生 T
  21. 未找到姓氏以该字母开头的医生 U
  22. 未找到姓氏以该字母开头的医生 V
  23. 未找到姓氏以该字母开头的医生 W
  24. 未找到姓氏以该字母开头的医生 X
  25. 未找到姓氏以该字母开头的医生 Y
  26. 未找到姓氏以该字母开头的医生 Z
重置所有过滤器

显示$起始范围 - $结束范围/源自可用$可用医生

姓氏首字母: T

  1. David D. Thiel, M.D.

    David D. Thiel, M.D.

    1. Urologist
    1. Jacksonville, FL
    擅长领域:

    Robotic surgery, Nephrectomy, Prostatectomy, Partial nephrectomy, Laparoscopic surgery, Robotic prostatectomy, Reconstr...uctive surgery, Kidney cancer, Kidney stone, Prostate cancer, Renal cell carcinoma

  2. Mark D. Tyson, II, M.D., M.P.H.

    Mark D. Tyson, II, M.D., M.P.H.

    1. Urologist
    1. Phoenix, AZ
    擅长领域:

    Bladder removal, Neobladder reconstruction, Retroperitoneal lymph node dissection for testicular cancer, Robotic prosta...tectomy, Orchiectomy, Urinary conduit surgery, Prostate cancer, Bladder cancer, Testicular cancer, Ureteral cancer

研究

Doctors and scientists in urology research at Mayo Clinic are studying new treatment options for prostate cancer and other urological conditions. Researchers are actively involved in studying long-term outcomes after radical prostatectomy. Research contributions improve outcomes and clinical practice, offering people access to novel therapies and trials before they're widely available.

For decades, Mayo Clinic has been compiling a database from records of people who have had surgery for prostate cancer. Mayo researchers use this information to monitor outcomes, search for trends and ensure an overall high quality of care.

Prostate cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.

The Department of Urology at Mayo Clinic is engaged in continuous research to advance treatments for prostate cancer and other urologic conditions. Recent studies include evaluating urology surgical team consistency on outcomes and on the use of magnets to optimize robotic prostatectomies. Other research has followed quality of life and operative outcomes after robotic prostatectomy. This type of research allows Mayo Clinic surgeons to provide the highest level of care for people who have these procedures.

Publications

See a list of publications about robotic prostatectomy by Mayo Clinic authors on PubMed, a service of the National Library of Medicine.

Research Profiles

Sept. 19, 2025
  1. Khanna A (voice recording). Mayo Clinic; recorded Oct. 2024.
  2. McVary KT. Surgical treatment of benign prostatic hyperplasia (BPH). https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  3. Health Education & Content Services. Your robotic-assisted prostate surgery. Mayo Clinic; 2024.
  4. Surgery for prostate cancer. Prostate Cancer Foundation. https://www.pcf.org/about-prostate-cancer/prostate-cancer-treatment/surgery-prostate-cancer/. Accessed July 28, 2025.
  5. Dmochowski RR, et al., eds. Simple prostatectomy — Open, laparoscopic, and robotic approaches. In: Campbell-Walsh-Wein Urology. 13th ed. Elsevier; 2026. https://www.clinicalkey.com. Accessed July 28, 2025.
  6. Surgery for prostate cancer. American Cancer Society. https://www.cancer.org/cancer/types/prostate-cancer/treating/surgery.html. Accessed July 28, 2025.
  7. Moreira DM, et al. Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy. BJU International. 2017; doi:10.1111/bju.13266.
  8. Motterle G, et al. The role of radical prostatectomy and lymph node dissection in clinically node positive patients. Frontiers in Oncology. 2019; doi:10.3389/fonc.2019.01395.
  9. Ami TR. Allscripts EPSi. Mayo Clinic. March 29, 2024.
  10. Costello AJ. Considering the role of radical prostatectomy in 21st century prostate cancer care. Nature Reviews Urology. 2020; doi:10.1038/s41585-020-0287-y.
  11. Agarwal DK, et al. Initial experience with da Vinci single-port robot-assisted radical prostatectomies. European Urology. 2020; doi:10.1016/j.eururo.2019.04.001.
  12. Ashfaq A, et al. Incidence and outcomes of ventral hernia repair after robotic retropubic prostatectomy: A retrospective cohort of 570 consecutive cases. International Journal of Surgery. 2017; doi:10.1016/j.ijsu.2016.12.034.
  13. Moris L, et al. Impact of lymph node burden on survival of high-risk prostate cancer patients following radical prostatectomy and pelvic lymph node dissection. Frontiers in Surgery. 2016; doi:10.3389/fsurg.2016.00065.
  14. Kaushik D, et al. Oncological outcomes following radical prostatectomy for patients with pT4 prostate cancer. International Brazilian Journal of Urology. 2016; doi:10.1590/S1677-5538.IBJU.2016.0290.
  15. Alshalalfa M, et al. Low PCA3 expression is a marker of poor differentiation in localized prostate tumors: Exploratory analysis from 12,076 patients. Oncotarget. 2017; doi:10.18632/oncotarget.15133.
  16. Preparing for surgery: Checklist. American Society of Anesthesiologists. https://www.asahq.org/madeforthismoment/preparing-for-surgery/prep/preparing-for-surgery-checklist/. Accessed July 28, 2025.
  17. Dess RT, et al. Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer. JAMA Oncology. 2020; doi:10.1001/jamaoncol.2020.0109.
  18. Richie JP. Radical prostatectomy for localized prostate cancer. https://www.uptodate.com/contents/search. Accessed July 28, 2025.
  19. He S, et al. Robot-assisted radical resection in prostate cancer comparative assessment with conventional laparoscopic prostatectomy: A retrospective comparative cohort study with single-center experience. Translational Andrology and Urology. 2022: doi: 10.21037/tau-22-739.
  20. Stringfield SB, et al. Experience with 10 years of a robotic surgery program at an academic medical center. Surgical Endoscopy. 2021; doi:10.1007/s00464-021-08478-y.
  21. Salinas CS, et al. Efficacy of robotic-assisted prostatectomy in localized prostate cancer: A systematic review of clinical trials. Advances in Urology. 2013; doi:10.1155/2013/105651.
  22. Kim DK, et al. Comparison of robot-assisted, laparoscopic, and open radical prostatectomy outcomes: A systematic review and network meta-analysis from KSER update series. Medicina. 2025; doi:10.3390/medicina61010061.
  23. Franco A, et al. Single port robot-assisted radical and simple prostatectomy: A systematic review and meta-analysis. Prostate Cancer and Prostatic Diseases. 2024; doi:10.1038/s41391-024-00787-2.
  24. Transurethral resection of the prostate (TURP). Mayo Clinic. https://www.mayoclinic.org/tests-procedures/turp/about/pac-20384880. Accessed Aug. 1, 2025.
  25. Prostate cancer. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/prostate-cancer/symptoms-causes/syc-20353087. Accessed Aug. 1, 2025.
  26. Azad AA, et al. Enzalutamide and prostate-specific antigen levels in metastatic prostate cancer: A secondary analysis of the ARCHES randomized clinical trial. JAMA Network Open. 2025; doi:10.1001/jamanetworkopen.2025.8751.
  27. Primary care management of the post prostate cancer patient. Video. Mayo Clinic; 2021. https://educationmedia.mayo.edu/media/Primary%20Care%20Management%20of%20the%20Post%20Prostate%20Cancer%20Patient/1_sqwb1249. Accessed Sept. 8, 2025.
  28. Spek A, et al. Single-fraction image-guided robotic radiosurgery efficiently controls local prostate cancer recurrence after radical prostatectomy. BJUI Compass. 2020; doi:10.1002/bco2.32.
  29. Turk H, et al. Predictive factors for biochemical recurrence in radical prostatectomy patients. Central European Journal of Urology. 2015; doi:10.5173/ceju.2015.606.
  30. Tugcu V, et al. Robot-assisted radical perineal prostatectomy: First experience of 15 cases. Turkish Journal of Urology. 2017; doi:10.5152/tud.2017.35488.
  31. Sharma NL, et al. Robotic-assisted laparoscopic prostatectomy. British Journal of Cancer. 2009; doi:10.1038/sj.bjc.6605341.
  32. Linder BJ, et al. Effect of surgical care team consistency during urologic procedures on surgical efficiency and perioperative outcomes. Urology. 2023; doi:10.1016/j.urology.2023.02.004.
  33. Steinberg, RL, et al. Magnet-assisted robotic prostatectomy using the da Vinci SP robot: An initial case series. Journal of Endourology. 2019; doi:10.1089/end.2019.0263.